Literature DB >> 3140483

Cellular DNA content and metastasis pattern in colorectal carcinomas.

C Rübe1, G Valet, M Eder.   

Abstract

Tissue samples from primary tumours and metastases obtained from surgical specimens and autopsies were investigated by flow cytometry for their DNA content. Of the 149 cases investigated, 124 autopsy cases of colorectal carcinoma were suitable for study. The pattern of metastatic spread in each individual case was analysed with reference to the autopsy records. A subgroup of euploid primary tumours was observed which should be considered separately with regard to its biological behavior, tumour location and extent of metastases. In these tumours, the liver was the first and final organ of haematogenic metastatic spread at an above-random frequency and a grossly metastatic liver with less than 15% of residual normal parenchyma was present at the same time. Furthermore, we observed stem-lines deviating in ploidy from the primary tumour in the metastases of nine cases. This indicates the chromosomal heterogeneity of colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140483     DOI: 10.1007/bf00716990

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  20 in total

Review 1.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

2.  [Classification and prognosis of colorectal cancers. Evaluation with multiparameter flow cytometry].

Authors:  R Wirsching; G Valet; B Wiebecke
Journal:  Fortschr Med       Date:  1985-06-06

3.  Simultaneous flow cytometric DNA and volume measurements of bone marrow cells as sensitive indicator of abnormal proliferation patterns in rat leukemias.

Authors:  G Valet; B Fischer; A Sundergeld; G Hanser; V Kachel; G Ruhenstroth-Bauer
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

4.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

5.  Preservation of cytometric DNA distribution and epithelial marker expression after tumor progression of human large bowel carcinomas.

Authors:  T O Rognum; E Thorud; P Brandtzaeg
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

6.  Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors.

Authors:  O S Frankfurt; H K Slocum; Y M Rustum; S G Arbuck; Z P Pavelic; N Petrelli; R P Huben; E J Pontes; W R Greco
Journal:  Cytometry       Date:  1984-01

7.  Characterization of two metastatic subpopulations originating from a single human colon carcinoma.

Authors:  E N Spremulli; C Scott; D E Campbell; N P Libbey; D Shochat; D V Gold; D L Dexter
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

8.  DNA stemline heterogeneity in colorectal cancer.

Authors:  W Hiddemann; D B Von Bassewitz; H J Kleinemeier; E Schulte-Brochterbeck; J Hauss; B Lingemann; T Büchner; E Grundmann
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

9.  Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer?

Authors:  P J Finan; P Quirke; M F Dixon; J E Dyson; G R Giles; C C Bird
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

10.  Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma.

Authors:  T O Rognum; E Thorud; K Elgjo; P Brandtzaeg; H Orjasaeter; K Nygaard
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

View more
  1 in total

1.  DNA-ploidy and survival in gastric carcinomas: a flow-cytometric study.

Authors:  G Baretton; O Carstensen; M Schardey; U Löhrs
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.